Home » Topics » Regulatory » Patents

Patents
RSS

BioWorld MedTech Patent Highlights: Week 44

From Current Patent Gazette

Nov. 12, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Boehringer Ingelheim presents new HER2 inhibitors

Nov. 12, 2021

New compounds inhibiting respiratory syncytial virus identified at Janssen

Nov. 12, 2021

Roche patents potassium voltage-gated channel subfamily C member 1 activators

Nov. 12, 2021

New MAP4K1 inhibitors discovered at Wigen Biomedicine Technology

Nov. 12, 2021

PharmaMar describes HER2-targeting antibody-drug conjugates

Nov. 12, 2021

XuanZhu Pharma divulges new DNA-dependent protein kinase inhibitors

Nov. 11, 2021

New GnRH-R antagonists identified at Shanghai Innofortune Biotech

Nov. 11, 2021

SyneuRx International patents DAAO and/or 3C-like proteinase inhibitors

Nov. 11, 2021

PharmaBlock Sciences discovers p300 and CREBBP inhibitors

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...